Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation
- PMID: 30689792
- PMCID: PMC6938207
- DOI: 10.1093/cid/ciz048
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation
Abstract
There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0-0.05 cases/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0-4.06 cases/100 person-years).
Keywords: Mycobacterium tuberculosis; LTBI; TB; allogeneic; hematopoietic cell transplantation.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Reply to Aronson et al.Clin Infect Dis. 2020 Mar 3;70(6):1262. doi: 10.1093/cid/ciz595. Clin Infect Dis. 2020. PMID: 31297517 No abstract available.
-
Incidence of Active Tuberculosis After Hematopoietic Cell Transplantation: A Small but Real Threat.Clin Infect Dis. 2020 Mar 3;70(6):1261-1262. doi: 10.1093/cid/ciz592. Clin Infect Dis. 2020. PMID: 31297538 No abstract available.
-
Reply to Singh.Clin Infect Dis. 2020 Jul 11;71(2):471-472. doi: 10.1093/cid/ciz981. Clin Infect Dis. 2020. PMID: 31584622 No abstract available.
-
Unique Rarity of Tuberculosis and Granulomatous Opportunistic Infections in Hematopoietic Cell Transplant Recipients.Clin Infect Dis. 2020 Jul 11;71(2):470-471. doi: 10.1093/cid/ciz979. Clin Infect Dis. 2020. PMID: 31584635 No abstract available.
References
-
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005; 172:1169–227. - PubMed
-
- Pai M, Kunimoto D, Jamieson F, Menzies D. Diagnosis of latent tuberculosis infection. Canadian tuberculosis standards 7th ed. 2014. Available at: https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/tbpc-lat....
-
- Cheng MP, Abou Chakra CN, Yansouni CP, et al. . Risk of active tuberculosis in patients with cancer: a systematic review and meta-analysis. Clin Infect Dis 2016; 64:ciw838. - PubMed
-
- Menzies D, Adjobimey M, Ruslami R, et al. . Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults. N Engl J Med 2018; 379:440–53. - PubMed
